Back to the future for multiple sclerosis therapy: focus on current and emerging disease-modifying therapeutic strategies | Immunotherapy
Mechanism of action of alemtuzumab. (a) Cellular targets of alemtuzumab... | Download Scientific Diagram
Interferons at age 50: past, current and future impact on biomedicine | Nature Reviews Drug Discovery
Mechanism of Action of Interferon Beta in Treatment of Multiple Sclerosis - ScienceDirect
References in Emerging injectable therapies for multiple sclerosis - The Lancet Neurology
Therapies for multiple sclerosis: translational achievements and outstanding needs: Trends in Molecular Medicine
Recent Advances in Nanomedicines for Multiple Sclerosis Therapy | ACS Applied Bio Materials
Interferon-β mechanisms of action in multiple sclerosis | Neurology
Rebif 44 mcg Ampoules - Rosheta
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System Medical Education on ReachMD
Disease-Modifying Therapies (Chapter 7) - Multiple Sclerosis
Mechanism of action of interferon beta-1b. | Download Scientific Diagram
Current immunotherapies for multiple sclerosis and neuromyelitis optica spectrum disorders: the similarities and differences
Interferon Beta Expression in MS | How Rebif® (interferon beta-1a) Works | HCPs
Biogen Idec: Evaluating a Potential Acquisition” - ppt video online download
Mechanisms of action of glatiramer acetate (GA) in MS. Reprinted from... | Download Scientific Diagram
The innovative development in interferon beta treatments of relapsing‐remitting multiple sclerosis - Madsen - 2017 - Brain and Behavior - Wiley Online Library
Two decades of subcutaneous glatiramer acetate injection: current role | PPA
Proposed Mechanism of Action (MOA) | OCREVUS® (ocrelizumab)
Mechanism of Action of Interferon Beta in Treatment of Multiple Sclerosis - ScienceDirect
The mechanism of action of interferon-[beta] in relapsing multiple sclerosis - Document - Gale Academic OneFile
A changing treatment landscape for multiple sclerosis: challenges and opportunities - Piehl - 2014 - Journal of Internal Medicine - Wiley Online Library
Cells | Free Full-Text | The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis | HTML
Differential mechanisms of action of interferon-β and glatiramer acetate in MS | Neurology
Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary | Nature Reviews Drug Discovery
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System Medical Education on ReachMD
